Author: United States. Federal Trade Commission. Bureau of Consumer ProtectionPublisher:
ISBN:
Category : Advertising
Languages : en
Pages : 32
Book Description
Dietary Supplements
Author: United States. Federal Trade Commission. Bureau of Consumer ProtectionPublisher:
ISBN:
Category : Advertising
Languages : en
Pages : 32
Book Description
Pharmacy Benefit Managers: Ownership of Mail-Order Pharmacies: A Federal Trade Commission Report
Author: Publisher: DIANE Publishing
ISBN: 1428952500
Category :
Languages : en
Pages : 240
Book Description
The Pharmaceutical Industry
Author: Roy LevyPublisher: DIANE Publishing
ISBN: 1428953639
Category : Antitrust law
Languages : en
Pages : 226
Book Description
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Index & Table of Cases 1981-2008
Author: Fordham Corporate Law InstitutePublisher:
ISBN:
Category :
Languages : en
Pages : 0
Book Description
Nominations to the U.S. Department of Commerce and the Federal Trade Commission
Author: United States. Congress. Senate. Committee on Commerce, Science, and TransportationPublisher:
ISBN:
Category :
Languages : en
Pages : 140
Book Description
Generic Drug Entry Prior to Patent Expiration
Author: United States. Federal Trade CommissionPublisher:
ISBN:
Category : Drugs
Languages : en
Pages :
Book Description
In April 2001, the Commission began an industry-wide study focused on certain aspects of generic drug competition under the Hatch-Waxman Amendments. The Amendments provide certain methods by which generic drug manufacturers can obtain approval to market a generic version of a brand-name product. The study's purpose was to provide a more complete picture of how generic drug competition has developed under one method the Amendments established: generic entry prior to expiration of the brand-name company's patents on the relevant drug product.
The Express Scripts/Medco Merger
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Competition Policy, and Consumer RightsPublisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 420
Book Description
Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing
Author: Publisher: DIANE Publishing
ISBN: 9781422322987
Category :
Languages : en
Pages : 186
Book Description
Paying Off Generics to Prevent Competition with Brand Name Drugs
Author: United States. Congress. Senate. Committee on the JudiciaryPublisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 184
Book Description